COMBIVAIR CAP

Uses:

Lamivudine and zidovudine are antiviral medications that prevent human immunodeficiency virus (HIV) from multiplying in your body. Lamivudine and zidovudine is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS).

This product contains 2 drugs: lamivudine and zidovudine. It is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Both lamivudine and zidovudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs).

Lamivudine/zidovudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

 

GENERIC NAME:

Budesonide + Formoterol Fumarate

DESCRIPTION:

Combivair Rotacaps is a combination of budesonide, a potent glucocrticoid and formoterol, a selective long-acting beta -agonist. 2 Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity. Formoterol is a very potent long-acting beta -agonist with a high intrinsic 2 activity and a rapid onset of action.

COMPOSITION:

Combivair 200 Rotacaps: Each capsule contains: Budesonide B.P. 200 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg Combivair 400 Rotacaps: Each capsule contains: Budesonide B.P. 400 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg

INDICATIONS:

Combivair Rotacap is indicated in the regular treatment of asthma, where use of a combination (long acting beta -agonist and inhaled 2 corticosteroid) has been found to be appropriate. Symptomatic treatment of severe chronic obstructive pulmonary disease (COPD) with a history of repeated exacerbations despite regular therapy with long acting bronchodilators. It is not indicated for the relief of acute bronchospasm.

DOSAGE & ADMINISTRATION:

Capsules are intended for use through Revolizer or Rotahaler only and are not to be swallowed. Dosage is individual and adjusted according to disease severity. When control has been achieved, the dose should be titrated to the lowest effective dose, which could include Combivair Rotacap given once daily.

CONTRAINDICATIONS:

Combivair Rotacap is contraindicated in patients with a history of hypersensitivity to any of the component of the drug product.

PRESENTATION:

1. Combivair 200 Rotacaps: Blister pack of 3 X 10’s Rotacaps.

2. Combivair 400 Rotacaps: Blister pack of 3 X 10’s Rotacaps.

Patients should consult with their physician before taking any medicine.